These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17717257)

  • 1. Urgent usage of sugammadex to treat residual neuromuscular blockade in the PACU.
    Jones PM; Turkstra TP
    Anesth Analg; 2007 Sep; 105(3):877; author reply 878. PubMed ID: 17717257
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudo-emergent use of an investigational drug.
    Rosman EJ
    Anesth Analg; 2007 Sep; 105(3):876; author reply 876, 878. PubMed ID: 17717255
    [No Abstract]   [Full Text] [Related]  

  • 3. Where's the Fire?
    Wax D
    Anesth Analg; 2007 Sep; 105(3):877-8; author reply 878. PubMed ID: 17717256
    [No Abstract]   [Full Text] [Related]  

  • 4. Was it a true emergency?
    Ziser A
    Anesth Analg; 2007 Sep; 105(3):876-7; author reply 878. PubMed ID: 17717254
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sugammadex, a novel drug for neuromuscular blockade reversal].
    Fernández Meré LA; Alvarez-Blanco M
    Rev Esp Anestesiol Reanim; 2010 Feb; 57(2):95-102. PubMed ID: 20337001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: sugammadex used to successfully reverse vecuronium-induced neuromuscular blockade in a 7-month-old infant.
    Buchanan CC; O'Donnell AM
    Paediatr Anaesth; 2011 Oct; 21(10):1077-8. PubMed ID: 21981096
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sugammadex: a new approach to muscle relaxation and its reversal].
    Duvaldestin P
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S39-40. PubMed ID: 19887275
    [No Abstract]   [Full Text] [Related]  

  • 8. Emergency use of sugammadex after failure of standard reversal drugs.
    Lenz A; Hill G; White PF
    Anesth Analg; 2007 Mar; 104(3):585-6. PubMed ID: 17312213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular transmission: new concepts and agents.
    de Boer HD
    J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
    Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications and clinical use of sugammadex].
    Debaene B; Meistelman C
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S57-63. PubMed ID: 19887279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex.
    Ren WH; Jahr JS
    Am J Ther; 2009; 16(4):295-9. PubMed ID: 19535969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sugammadex: something new to improve patient safety or simply a gadget?].
    Plaud B
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S64-9. PubMed ID: 19887280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology and efficacy of sugammadex in the reversal of neuromuscular blockade.
    Schaller SJ; Lewald H
    Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1097-108. PubMed ID: 27463265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux!
    Lee C; Katz RL
    J Crit Care; 2009 Mar; 24(1):43-9. PubMed ID: 19272538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical pharmacology of sugammadex.
    Bom A; Hope F; Rutherford S; Thomson K
    J Crit Care; 2009 Mar; 24(1):29-35. PubMed ID: 19272536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The concept behind sugammadex.
    Epemolu O; Bom A
    Rev Esp Anestesiol Reanim; 2014 May; 61(5):272-6. PubMed ID: 24636599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugammadex in anesthesia practice.
    Duvaldestin P; Plaud B
    Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
    Mosing M; Auer U; West E; Jones RS; Hunter JM
    Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.